RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature

MA Chapman; J Sive; J Ambrose; C Roddie; N Counsell; A Lach; M Abbasian; R Popat; JD Cavenagh; H Oakervee; MJ Streetly; S Schey; M Koh; F Willis; AE Virchis; J Crowe; MF Quinn; G Cook; CR Crawley; G Pratt; M Cook; N Braganza; T Adedayo; P Smith; L Clifton-Hadley; RG Owen; Pieter Sonneveld; JJ Keats; J Herrero; K Yong

doi:10.1182/blood-2018-05-849893

RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature

MA Chapman
, J Sive
, J Ambrose
, C Roddie
, N Counsell
, A Lach
, M Abbasian
, R Popat
, JD Cavenagh
, H Oakervee
, MJ Streetly
, S Schey
, M Koh
, F Willis
, AE Virchis
, J Crowe
, MF Quinn
, G Cook
, CR Crawley
, G Pratt

M Cook, N Braganza, T Adedayo, P Smith, L Clifton-Hadley, RG Owen, Pieter Sonneveld, JJ Keats, J Herrero, K Yong

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

18 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2154-2165
Number of pages	12
Journal	Blood
Volume	132
Issue number	20
DOIs	https://doi.org/10.1182/blood-2018-05-849893
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1182/blood-2018-05-849893

http://hdl.handle.net/1765/112321

Cite this

Chapman, MA., Sive, J., Ambrose, J., Roddie, C., Counsell, N., Lach, A., Abbasian, M., Popat, R., Cavenagh, JD., Oakervee, H., Streetly, MJ., Schey, S., Koh, M., Willis, F., Virchis, AE., Crowe, J., Quinn, MF., Cook, G., Crawley, CR., ... Yong, K. (2018). RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature. Blood, 132(20), 2154-2165. https://doi.org/10.1182/blood-2018-05-849893

@article{83f9784bd6134183b9f8db022aefdd9b,

title = "RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature",

author = "MA Chapman and J Sive and J Ambrose and C Roddie and N Counsell and A Lach and M Abbasian and R Popat and JD Cavenagh and H Oakervee and MJ Streetly and S Schey and M Koh and F Willis and AE Virchis and J Crowe and MF Quinn and G Cook and CR Crawley and G Pratt and M Cook and N Braganza and T Adedayo and P Smith and L Clifton-Hadley and RG Owen and Pieter Sonneveld and JJ Keats and J Herrero and K Yong",

year = "2018",

doi = "10.1182/blood-2018-05-849893",

language = "Undefined/Unknown",

volume = "132",

pages = "2154--2165",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

number = "20",

}

Chapman, MA, Sive, J, Ambrose, J, Roddie, C, Counsell, N, Lach, A, Abbasian, M, Popat, R, Cavenagh, JD, Oakervee, H, Streetly, MJ, Schey, S, Koh, M, Willis, F, Virchis, AE, Crowe, J, Quinn, MF, Cook, G, Crawley, CR, Pratt, G, Cook, M, Braganza, N, Adedayo, T, Smith, P, Clifton-Hadley, L, Owen, RG, Sonneveld, P, Keats, JJ, Herrero, J & Yong, K 2018, 'RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature', Blood, vol. 132, no. 20, pp. 2154-2165. https://doi.org/10.1182/blood-2018-05-849893

TY - JOUR

T1 - RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature

AU - Chapman, MA

AU - Sive, J

AU - Ambrose, J

AU - Roddie, C

AU - Counsell, N

AU - Lach, A

AU - Abbasian, M

AU - Popat, R

AU - Cavenagh, JD

AU - Oakervee, H

AU - Streetly, MJ

AU - Schey, S

AU - Koh, M

AU - Willis, F

AU - Virchis, AE

AU - Crowe, J

AU - Quinn, MF

AU - Cook, G

AU - Crawley, CR

AU - Pratt, G

AU - Cook, M

AU - Braganza, N

AU - Adedayo, T

AU - Smith, P

AU - Clifton-Hadley, L

AU - Owen, RG

AU - Sonneveld, Pieter

AU - Keats, JJ

AU - Herrero, J

AU - Yong, K

PY - 2018

Y1 - 2018

U2 - 10.1182/blood-2018-05-849893

DO - 10.1182/blood-2018-05-849893

M3 - Article

C2 - 30181174

SN - 0006-4971

VL - 132

SP - 2154

EP - 2165

JO - Blood

JF - Blood

IS - 20

ER -